1) Should a large IVD sign, how will ADO communicate to the market the value of that deal as there may be a potential risk that the market undervalues the signing.
Also (following a large IVD signing and resulting larger scale validation of mix n go) are there any thoughts about communicating to the public at large what mix n go can do for them diagnostic wise, e.g. a 60 minutes story
2) If we have one large IVD currently undertaking a commercial batch test with mix n go and say we say that that company is 95% through their full assessment process, how far through might some of the other larger IVD companies be. I understand this will be hugely judgement based on Geoffs part and that each company may have different approaches to their assessment. But what I'm looking at more is should one or two companies delay their assessments or protract formal contract signings, are there other companies close behind who may be drawing to the stage where they themselves are looking at saying formally yes or no and entering contract arrangements.
3) While revenues from Bangs and Mueck were never going to be company making, they were a little disappointing for 2010/11. Does Geoff have any comments
ADO Price at posting:
6.9¢ Sentiment: LT Buy Disclosure: Held
